Background {#Sec1}
==========

With an aging population, the impact of age-related cognitive impairment is increasing \[[@CR1]--[@CR4]\]. Cognitive impairment can involve many symptoms, including memory loss, newfound difficulties with language, and inability to make every-day decisions \[[@CR5]\]. Further, the incidence of many dementias for which aging is the major risk factor is increasing. For example, Alzheimer's Disease (AD), with approximately 5.4 million people affected in the 2016, is expected to increase to over 13 million in the next few years \[[@CR6]\]. The majority of clinical trials for AD therapeutics have focused on reducing hallmark pathologies such as amyloid beta accumulation and tau tangles. However, these pathologies do not always correlate to cognitive function, and therefore these therapeutic targets may not rescue the symptoms that ultimately burden the patient \[[@CR7], [@CR8]\]. Currently, despite numerous preclinical studies and clinical trials, there are no therapies for cognitive decline.

Non-pharmacological interventions have been proposed as alternatives to pharmacological treatments to prolong brain health -- reducing risk for age-related cognitive decline and dementias. Obesity and physical inactivity increase risk for cognitive decline and dementia, suggesting that interventions such as diet and exercise can mitigate risk \[[@CR9]\]. Exercise has positive effects, not just improving systemic health, but also cerebral health through increases in cerebral plasticity, neurogenesis, as well as hippocampal and cortical volume \[[@CR10], [@CR11]\]. Exercise earlier in life correlated with reduced cognitive impairment with age \[[@CR12]\]. The cerebral benefits of exercise may arise through the induction of brain derived neurotropic factor (BDNF), which triggers neuronal proliferation in the dentate gyrus \[[@CR13]\]. A recent study has also explored the use of running, as well as an AAV-based gene therapy to increase neuronal proliferation and survival, in a mouse model of AD \[[@CR14]\]. Viral-induced neurogenesis alone did not benefit cognition as well as running did, suggesting that running also promotes non-neuronal changes that improve cognition. Therefore, the full spectrum of processes by which running promotes brain health and reduces risk for dementias remains unclear. Furthermore, given that many such studies are performed in young mice, it remains unknown whether the beneficial effects of running persist through multiple life stages.

Here, we chose an unbiased transcriptional profiling approach to better understand the effects of running on overall brain health. To date, an extensive evaluation of the transcriptome of the brain in response to running across ages has not been assessed. RNA sequencing was performed on the cortex and hippocampus from young and middle aged (midlife) C57BL/6 J (B6) male mice that were provided running wheels for 12 weeks. Transcriptional profiles were compared to aged-matched sedentary controls. Within the midlife running cohort, half the mice ran markedly faster and farther (high runners) than the other half (low runners). This provided natural variation in our midlife running dataset and allowed us to also interrogate how the intensity of running impacted systemic health as well as transcriptional profiles in the brain. The young cohort did not exhibit such variation in their voluntary exercise. Transcriptomes of young running mice showed considerably more differentially expressed (DE) genes compared to either low-running or high-running midlife cohorts. Gene set enrichment analyses revealed enrichment of genes in pathways implicated in vascular remodeling in young, but not midlife mice.

Results {#Sec2}
=======

Voluntary running distances at midlife showed a bimodal distribution {#Sec3}
--------------------------------------------------------------------

To understand the molecular changes in the brain in response to voluntary running, running wheels were provided to young (1--2 month old, mo) and midlife (12 mo) C57BL/6 J (B6) male mice for 12 weeks. Age-matched sedentary controls had no access to a running wheel (Fig. [1](#Fig1){ref-type="fig"}a). To quantify running, wheel rotations per minute were assessed overnight, when mice are most active, for at least five nights during the last week of the experiment. These data were used as an estimate for the overall running performed during the 12 weeks. Although there was some variation between average wheel rotations per night in the young cohort, five of six mice averaged over 10,000 rotations per night. Of the 12 midlife running mice however, half averaged fewer than 10,000 rotations per night deemed 'Low Runners' (gray), and half averaged greater than 10,000 rotations per night, deemed 'High Runners' (black) (Fig. [1](#Fig1){ref-type="fig"}b). Of the minutes active, the high running cohort ran faster (average rotations per minute of active minutes) than the low running cohort (Fig. [1](#Fig1){ref-type="fig"}c). Direct comparison of speed and distance between midlife low and high runners revealed significant differences (*p* \< 0.001) (Fig. [1](#Fig1){ref-type="fig"}d, Additional file [1](#MOESM1){ref-type="media"}: Figure S1A). This was not due to dominance in group housing (Additional file [9](#MOESM9){ref-type="media"}: Table S1). High runners ran a similar distance (on average, greater than 10,000 rotations per night) to young runners. Additionally, midlife high runners spent more time running compared to midlife low runners (Additional file [1](#MOESM1){ref-type="media"}: Figure S1B). High runners also were quantified to have run at 100 rotations per minute, while the low runners did not show this ability (Additional file [1](#MOESM1){ref-type="media"}: Figure S1C). Young sedentary mice gained more weight over the course of the experiment than young running mice (Fig. [1](#Fig1){ref-type="fig"}e, f). There was no significant difference in weight from the start of the experiment to the end between midlife running and midlife sedentary mice (Fig. [1](#Fig1){ref-type="fig"}f, Additional file [1](#MOESM1){ref-type="media"}: Figure S1D). To better understand body composition in the midlife cohort, mice were subjected to NMR a week before harvest to assess fat and lean mass percentages. Midlife high runners showed a significant decrease in fat mass (g) reflected by a corresponding decrease in adiposity (%fat) (Additional file [1](#MOESM1){ref-type="media"}: Figure S2A, S2B, S2D). Lean muscle mass was not different among the groups but the midlife high running cohort had a higher percent lean muscle mass compared to low running and sedentary cohorts, presumably due to the lower body weight of the high runners (Additional file [1](#MOESM1){ref-type="media"}: Figure S2C, S2E). This indicates that the weight composition was more favorable (high lean muscle percentage, low fat percentage) in the high runners compared to the other midlife mice. Fig. 1Voluntary Running at young and midlife reveals natural variation in running intensity. **a** Experimental strategy of running mice. Young mice were given access to voluntary running wheels for 12 weeks starting at 1--2 months of age and ending at 4--5 months of age. Midlife mice were given access to wheels for 12 weeks starting at 12 months of age and ending at 15 months of age. **b** Average wheel rotations per night showed dichotomous response of midlife running. Midlife mice that ran below 10,000 rotations per night (red line), were deemed 'Low' (grey). Midlife mice that ran above 10,000 rotations per night, deemed 'High' (black). **c** Graph of distance vs speed showed differences between low and high running groups; all midlife high runners trended faster and farther than midlife low runners. **d** Midlife running speed between low and high runner groups showed a significant difference (*p* \< 0.001). **e** Weight over the course of running experiment. **f** Change in weight of each cohort from start to end of the experiment (*p* \< 0.001)

To assess whether running during midlife altered metabolic indicators of health in the blood, we measured cholesterol composition, non-fasted glucose, triglycerides, and non-esterified fatty acids (NEFA) levels. Total cholesterol was significantly reduced in young runners compared to age-matched sedentary controls (Fig. [2](#Fig2){ref-type="fig"}a). Midlife high runners also showed a significantly lower total cholesterol profile compared to midlife sedentary controls, which could be attributed to the decrease in LDL cholesterol (Fig. [2](#Fig2){ref-type="fig"}a-c). HDL cholesterol remained unchanged with running (Fig. [2](#Fig2){ref-type="fig"}c). Non-fasted glucose levels were not significantly different, although there was trend towards lower blood glucose in running compared to sedentary mice at both ages (Fig. [2](#Fig2){ref-type="fig"}d). Triglycerides and NEFA were reduced by running at a young age, but this effect was not seen in the midlife cohort (Fig. [2](#Fig2){ref-type="fig"}e, f). Taken together, there was a significant shift towards a healthier body composition and blood profile in midlife high runners compared to low runners. Further, systemic health benefits such as levels of total cholesterol, including LDL, can be altered at midlife due to more intense running. Fig. 2Lipid profiling of the blood showed ability to alter cholesterol composition in midlife. **a** Significant difference in total cholesterol plasma concentration at harvest in young runners and between midlife high runners to midlife sedentary mice (young \**p* = 0.0124, midlife \**p* = 0.0282). **b** No significant difference in High Density Lipoprotein (HDL) plasma concentration between runners and sedentary mice. **c** Significant difference in Low Density Lipoprotein (LDL) plasma concentration between midlife high runners and midlife sedentary mice (\**p* = 0.0489). **d** No change in non-fasted glucose plasma concentration across all cohorts. **e** Significant decrease in in plasma triglyceride between young run and young sedentary concentration (\**p* = 0.0151). **f** Significant reduction in Non-Esterified Fatty Acid (NEFA) plasma concentrations between young run and young sedentary cohorts (\**p* = 0.0374)

Young running affects transcriptional signatures more robustly than midlife running {#Sec4}
-----------------------------------------------------------------------------------

To assess transcriptional changes in the brain after running at two different ages, RNA-seq was performed on hippocampus and cortex -- vulnerable regions in age-related cognitive decline and dementia (Additional file [1](#MOESM1){ref-type="media"}: Figures S3 and S4). Differentially expressed (DE) genes (FDR \< 0.05) were identified by comparing (i) young running to young sedentary, (ii) midlife high runners to midlife sedentary, and (iii) midlife low runners compared to midlife sedentary (Additional file [2](#MOESM2){ref-type="media"}: Table S2, Additional file [3](#MOESM3){ref-type="media"}: Table S3, Additional file [4](#MOESM4){ref-type="media"}: Table S4, Additional file [5](#MOESM5){ref-type="media"}: Table S5, Additional file [6](#MOESM6){ref-type="media"}: Table S6, Additional file [7](#MOESM7){ref-type="media"}: Table S7 and Additional file [8](#MOESM8){ref-type="media"}: Table S8, Additional file [1](#MOESM1){ref-type="media"}: Figure S5, see [Methods](#Sec10){ref-type="sec"}). In the cortex, there were 1252 DE genes (742 upregulated, 510 downregulated) when comparing young runners to young sedentary mice (Fig. [3](#Fig3){ref-type="fig"}a, b). However, there were only 214 DE genes (70 upregulated, 144 downregulated) in the midlife high runners compared to midlife sedentary, and 67 DE genes (20 upregulated and 47 downregulated) comparing midlife low runners to midlife sedentary (Fig. [3](#Fig3){ref-type="fig"}b). Hippocampal analysis revealed similar results to the cortex. In young mice there were 2026 DE genes (1498 upregulated, 528 downregulated) in the young runners compared to young sedentary (Fig. [3](#Fig3){ref-type="fig"}f, g). In midlife mice, there were 271 DE genes (87 upregulated, 184 downregulated) comparing midlife high runners to midlife sedentary controls, and 172 DE genes (80 upregulated, 92 downregulated) comparing midlife low runners to midlife sedentary controls (Fig. [3](#Fig3){ref-type="fig"}g). These results show that transcriptionally, running at a young age has a far greater effect on the number of DE genes than at midlife. Fig. 3RNA-seq analysis identified ECM-related enrichment in both the cortex and hippocampus of young runners. **a** Cortical region (purple) used for RNA-seq. **b** Number of DE genes (FDR \< 0.05) found in the cortex of the young runners compared to young sedentary ('Young Run'), midlife low runners compared to midlife sedentary ('Low Run'), and midlife high runners compared to midlife sedentary ('High Run') (FDR \< 0.05). **c** IPA canonical pathway analysis showed enriched 'Hepatic Fibrosis' and 'GP6 Signaling Pathway' in the cortex of young run compared to young sedentary, however not significant in midlife comparisons. **d** KEGG pathway enrichment analysis in the cortex for young run compared to young sedentary (FDR \< 0.05). **e** GO term enrichment analysis in the cortex for young run compared to young sedentary (FDR \< 0.05). **f** Hippocampal region (green) used for RNA-seq tissue submission. **g** Number of DE genes (FDR \< 0.05) found in the hippocampus of the young runners compared to young sedentary ('Young Run'), midlife low runners compared to midlife sedentary ('Low Run'), and midlife high runners compared to midlife sedentary ('High Run') (FDR \< 0.05). **h** IPA canonical pathway analysis showed enriched 'Hepatic Fibrosis' and 'GP6 Signaling Pathway' in the hippocampus of young run compared to young sedentary, however not significant in midlife comparisons. **i** KEGG pathway enrichment analysis in the hippocampus for young run compared to young sedentary (FDR \< 0.05). **j** GO term enrichment analysis in the hippocampus for young run compared to young sedentary (FDR \< 0.05)

Extracellular matrix-related genes are altered in young but not midlife runners {#Sec5}
-------------------------------------------------------------------------------

Next, we sought to identify which pathways and genes were significantly altered by running at a young age, but showed no difference at midlife. We first analyzed transcriptional data through Ingenuity Pathway Analysis (IPA) canonical pathway analysis. DE genes comparing young runners to young sedentary controls were enriched for canonical pathway terms 'Hepatic Fibrosis', 'GP6 Signaling', and 'Circadian Rhythm Signaling' in the cortex and hippocampus. (Fig. [3](#Fig3){ref-type="fig"}c, h). These pathways were not enriched in the midlife data. 'Hepatic Fibrosis' and 'GP6 Signaling Pathway' terms contain extracellular matrix (ECM)-related genes, such as collagens and laminins. KEGG pathway analysis further identified 'ECM-receptor Interaction' and 'Focal Adhesion' in the cortex and hippocampus, which substantiated the significant changes to the ECM (Fig. [3](#Fig3){ref-type="fig"}d, i). There were no KEGG terms enriched in either the cortex or hippocampus for the midlife low runners. Only the KEGG pathway 'Malaria' was enriched in the cortex of midlife high runners. Genes DE in the 'Malaria' pathway are primarily hemoglobin-related genes suggesting a potential change in oxygenation in high runners. Only the KEGG pathway 'ECM-receptor Interaction' was enriched in the hippocampus of midlife high runners. Of the ten DE genes in 'ECM-receptor Interaction' were seven collagen or laminin genes (*Col24a1* (FDR = 2.39e-6, FC = − 2.17), *Col6a3* (FDR = 0.026,FC = − 1.38), *Col6a2* (FDR = 0.0032,FC = -1.45), *Col6a5* (FDR = 0.00029,FC = − 1.72), *Col6a1* (FDR = 0.00025,FC = − 1.52), *Col5a1* (FDR = 9.03e-8,FC = − 1.75), and *Lamc2* (FDR = 6.85e-8,FC = − 2.07)) which were all downregulated. This suggests that more intense running at midlife can influence ECM-related genes, but potentially not in a positive way.

GO terms are a way of categorizing DE genes into functional biological groups. GO term analysis of the DE genes from the cortex and hippocampus data from young runners showed enrichment for 'ECM Organization' and 'Cell Adhesion' (Fig. [3](#Fig3){ref-type="fig"}e, j). Interestingly, vascular remodeling-related terms were significantly enriched in the cortex of young runners, including terms such as 'blood vessel remodeling', 'ECM Organization', 'Angiogenesis', and 'Cell Adhesion' (Fig. [3](#Fig3){ref-type="fig"}e). None of these terms were enriched in the midlife data, irrespective of distance ran. However, one GO term, 'Cellular Oxidant Detoxification', which comprised mainly hemoglobin component genes, was enriched in both low and high runners in the hippocampus but only in the high runners of the cortex at midlife. These data suggest there is an overall change in ECM composition or organization due to running at a young age that is not reflected to the same degree at midlife. (Fig. [3](#Fig3){ref-type="fig"}).

Running upregulates genes related to vascular remodeling in young but not midlife mice {#Sec6}
--------------------------------------------------------------------------------------

IPA revealed 'Hepatic Fibrosis' and 'GP6 Signaling' as significantly enriched canonical pathways in both the cortex and the hippocampus (Fig. [3](#Fig3){ref-type="fig"}). These pathways contain many collagens and laminins that comprise the basement membrane component of the blood brain barrier that is important for maintaining brain health (Fig. [4](#Fig4){ref-type="fig"}a). The majority of genes in 'GP6 Signaling' pathway were upregulated in the young runners in both the cortex and hippocampus but were not DE in either midlife high or low runners (Fig. [4](#Fig4){ref-type="fig"}b-f). Fig. 4General upregulation of Collagens and Laminins due to young running with an attenuated response at midlife. **a** Number of significant collagen, laminin or other genes in young 'Hepatic Fibrosis' and 'GP6 Signaling' pathways in the cortex and hippocampus. **b** Fold changes of genes enriching for 'GP6 Signaling' in the cortex. **c** Fold changes of genes enriching for 'GP6 Signaling' in the hippocampus. **d** Heatmap of Col4s and laminins in the cortex and hippocampus that are significant in young run compared to young sedentary, while not significant in midlife comparisons. **e** Examples of significant cortical genes found in (**d**) showing attenuated responses in midlife cohort contrasts compared to young. **f** Examples of significant hippocampal genes found in (**d**) showing various responses in midlife cohort contrasts compared to young

GO term analysis identified enrichment of 'ECM organization', 'Blood Vessel Remodeling' and 'Angiogenesis' in the cortex (Fig. [5](#Fig5){ref-type="fig"}a). These terms were significantly enriched in young mice but not in midlife mice. Of these vascular terms, 'Angiogenesis' contained 32 genes (26 upregulated, 6 downregulated) (Fig. [5](#Fig5){ref-type="fig"}a, b). At least six of the upregulated DE genes are implicated in *Vegf*-induced angiogenesis (*Mmp14* (FDR = 1.23e-8, FC = 1.75), *Vegfa* (FDR = 0.038, FC = 1.20), *Kdr* (FDR = .0011, FC = 1.41), *Flt1* (FDR = .031, FC = 1.21), *Dll4* (FDR = 0.037, FC = 1.59), *Notch1* (FDR = 0.002, FC = 1.29)) (Fig. [5](#Fig5){ref-type="fig"}c, d) \[[@CR15]\]. However, of the 26 DE genes that were significantly upregulated in young runners compared to young sedentary, only two genes (*Col8a1*, *Hif3a*) were significantly DE in midlife high runners when compared to midlife sedentary controls (Fig. [5](#Fig5){ref-type="fig"}c-d). Fig. 5Angiogenesis genes are significantly enriched in young runners but not midlife runners. **a** GO terms enriched for vascular remodeling in the cortex show general upregulation. **b** Fold changes for DE genes enriched in the Angiogenesis term in the cortex. **c** Heatmap comparison between angiogenesis gene fold changes in the cortex in the young contrast (all significant) and midlife contrasts. **d** Examples of significant cortical angiogenesis genes found in (**c**) showing various responses in midlife cohort contrasts compared to young

Running activates genes in multiple cerebrovascular-related cell types {#Sec7}
----------------------------------------------------------------------

Finally, we determined whether specific cell types were more dramatically affected by young but not midlife running. This might provide insight into which cell type(s) are no longer responding to running in midlife mice. A sample of basement membrane and angiogenesis genes DE in young, but not midlife, running datasets were cross referenced to two cell-type specific datasets -- the Brain RNA seq and a single cell RNA-seq dataset focused on cerebrovascular associated cells \[[@CR16], [@CR17]\]. First, we evaluated *Col4* and laminin genes that were DE in young runners. As expected, the majority of the genes were expressed by cerebrovascular-related cells such as astrocytes and endothelial cells and not other cells in brain such as neurons, oligodendrocytes and microglia (Additional file [10](#MOESM10){ref-type="media"}: Table S9). However, many genes were expressed by different subsets of vascular-related cells such as *Col4a1* (endothelial cells, pericytes, vascular smooth muscle cells and fibroblasts) *Lamb2* (astrocytes, endothelial cells, pericytes, vascular smooth muscle cells and fibroblasts) and *Lama5* (astrocytes, endothelial cells and vascular smooth muscle cells) (Additional file [1](#MOESM1){ref-type="media"}: Figure S6). Second, we assessed cell type specific expression of angiogenesis genes. Upstream components of the angiogenesis pathway were mainly expressed by astrocytes, including *Mmp14* and *Vegfa* (Fig. [6](#Fig6){ref-type="fig"}a, b). Downstream components of the angiogenesis pathway were primarily expressed by endothelial cells (*Kdr*, *Flt1*, *Dll4*, *Notch1*). Therefore, ECM- and angiogenesis-related genes affected by running are expressed in multiple cell types relevant to the cerebrovasculature. The results are summarized in Fig. [7](#Fig7){ref-type="fig"}. Fig. 6Angiogenesis genes are primarily expressed in astrocytes and endothelial cells. **a**. Expression of *Mmp14* is primarily produced in pericytes and astrocytes. **b** Expression of Vegfa is primarily produced by astrocytes. **c** Expression of *Flt1* is primarily produced in endothelial cells. **d** Expression of *Dll4* is primarily produced in endothelial cells. Cell type specific expression reproduced from Zheng et al. (left), and Vanlandewijck and He et al. (right) Fig. 7Running young is more effective than running at midlife. **a** Depiction of transcriptional changes occurring in a young mouse due to running, including upregulation of collagens and laminins from astrocytes, pericytes and endothelial cells, as well as induction of the VEGFA-KDR-DLL4 angiogenesis pathway. **b** Depiction of molecular changes occurring in midlife mice due to running, including downregulation of collagens and laminins, and a trend for induction of early angiogenesis genes from astrocytes (MMP14, VEGFA) but an attenuated downstream angiogenesis response (FLT-1, DLL4, NOTCH1) in endothelial cells

Discussion {#Sec8}
==========

Here, we assessed B6 male mice at two ages, young and midlife, to better understand the effects of running on the aging brain. Our data show early indication that intervention of running may not be as beneficial to the cerebrovasculature in midlife as it is at a young age. While systemic health (lipid profile, body composition) is improved by running at midlife, transcriptional profiling of the hippocampus and cortex showed fewer genes impacted during midlife, specifically in the cerebrovasculature. This suggests there may be a reduced responsiveness to running by specific cerebrovascular cell types in these brain regions with age. Therapies or interventions during midlife may require different approaches than preventative measures in young, more responsive individuals. In this study, half the midlife cohort (high runners) ran as much as the young cohort, whereas the other half ran far less (low runners, Fig. [1](#Fig1){ref-type="fig"}). Interestingly, this did not drastically affect the transcriptional profiles (Fig. [3](#Fig3){ref-type="fig"}). We would have anticipated that running further and faster would have been more beneficial at midlife, however, our results show a mitigated transcriptional response in all midlife runners compared to young runners.

Previous exercise studies in mouse models have primarily focused on the benefits of exercise in young rodents. Findings from these experiments are promising, showing that running can reduce amyloid plaque development, induce neurogenesis, reduce infarct volume, and improve cognition \[[@CR14], [@CR18]--[@CR20]\]. However, the brain during development and early adult life is considered more plastic than in later life, which indicates that therapies found to be beneficial in young, may not properly translate to aged trials \[[@CR2], [@CR21]\].

We took an unbiased approach to identify transcriptional changes in two vulnerable brain regions (cortex and hippocampus) as a result of running. We show that many of the transcriptional changes as a result of running were to genes relevant to the cerebrovasculature. Particularly, we highlight genes involved in basement membrane composition (particularly collagens and laminins) that are upregulated in young mice due to running that were not affected by running at midlife. Similarly, genes in the angiogenesis pathway (e.g. *Mmp14*, *Vegfa*, *Kdr*, *Flt1, Dll4,* and *Notch1*) showed induction by running in young but not midlife mice \[[@CR15]\]. These transcriptional data suggest that the benefits of exercise to the cerebrovasculature declines with age, increasing the need for a greater understanding of midlife exercise as an intervention to improve cerebrovascular health \[[@CR22]\].

Previous studies have focused on the neuroprotective benefits of exercise. In Choi et al., of the 5XFAD mice (a model relevant to AD) that were exercised, half were categorized as showing increased neurogenesis while the other half did not show this effect, potentially due to the amount run \[[@CR14]\]. Additionally, it was shown that viral-induced neurogenesis was not enough to rescue cognitive decline, while exercise-induced neurogenesis was able to sufficiently improve cognitive results \[[@CR14]\]. This finding indicates that running is providing additional benefits to substantiate neurogenesis mediated improvements in cognition. Based on the results of our study, we predict that in Choi et al. there were running-induced improvements to the cerebrovasculature which would provide better clearance of amyloid and better maintenance of neuronal health resulting in improved cognition \[[@CR14]\]. It is known that the development of the neuronal and vasculature systems is strongly linked, with growth occurring simultaneously because neurons require vascular support for oxygen and nutrients. This further supports the need for cerebrovascular improvement to accompany adult therapy-induced neurogenesis \[[@CR23]\]. If neurogenesis and angiogenesis become uncoupled, this may cause stress to neurons, reduced cerebral blood flow, and a disruption to neurovascular coupling. Therefore, when considering midlife interventions to cognitive decline and dementia it is important to consider both neuronal and cerebrovascular health.

Our study assessed both distance and intensity of running. Although most previous studies tend to only report time allotted for running, a few studies included more detailed breakdown of running data. For instance, in one study, young (3mo) and aged (19mo) male mice were analyzed for total distance over a day and had no significant difference with 3.0 ± 0.12 miles/day for young, and 2.4 ± 0.06 miles/day for old \[[@CR11]\]. The mice used in this study had an average of 1.32 ± 0.69 miles/12 h for young mice, 0.28 ± 0.13 miles/12 h for midlife low runners, and 2.00 ± 0.50 miles/12 h for midlife high runners. Results from this study found that there was a distinct loss of vascular plasticity in older mice, substantiating the findings from our study \[[@CR11]\]. Another study in young C57BL/6 J female mice explored differential gene expression in the striatum after 16 days of running in conjunction with voluntary ethanol consumption. The female running mice revealed 1305 DE genes due to wheel running, compared to our 1252 in DE genes in the young running cortex, and 2026 DE genes in the young running hippocampus \[[@CR24]\]. Running distances cannot be compared as Darlington et al. used a vertical, external to the cage, larger diameter, running wheel design, dissimilar to the one used in our study \[[@CR24]\].

One limitation of our study is that we used healthy wild-type male mice to assess the effects of exercise at two different ages. In our study, the effects of exercise were greater in young compared to midlife male mice. Future studies are necessary to understand the sex-specific effects of running, and how these differences might play a role in exercise-induced transcriptional differences. Additionally, this study did not extend past transcriptional profiling. Further assessment of vascular density and functional testing of responsiveness through cerebral blood flow (CBF) measurements would aid in our understanding of how running improves cerebrovascular health through aging. Moreover, C57BL/6 J do not show cognitive decline at these early and midlife ages, so cognition was not assessed. Determining the relationship between cerebrovascular health and cognition are still required. It is also not clear how running impacts cerebrovascular health in humans and animal models predisposed to vascular damage and dementia through genetic or environmental risk factors.

Due to the increasing recognition of a vascular contribution to dementia symptomology, it would be pertinent to know if running alleviates these effects of vascular risk in genetically predisposed mice at different ages. For example, the *ε4* allele of apolipoprotein E *(APOE*^*ε4*^), the greatest risk factor for late-onset AD and Vascular Dementia, is associated with early cerebrovascular decline in both mice and humans \[[@CR25], [@CR26]\]. This is proposed to be due to a lack of binding of *APOE*^*ε4*^ to the low-density lipoprotein receptor related protein 1 (*LRP1*) leading to an increase in *MMP9* and a breakdown of basement membrane proteins and endothelial cell tight junctions \[[@CR25]\]. Therefore, when evaluating running as a potential intervention, it is imperative to understand whether benefits will be seen across multiple dementia risk genotypes. Although these experiments are challenging to perform in human populations, they can be readily performed in mouse models.

Due to the heterogeneity of dementia pathology, it is possible that the typical approach to treating dementias, is too narrow in scope, only able to alleviate the burden of a small subset of dementia cases. Only recently has the American Heart Association acknowledged the prevalence of Vascular Contributions to Cognitive Impairment and Dementia (VCID), explaining that cerebral infarcts are frequent and common with age, including in patients with diagnosed with AD \[[@CR27]\]. We hypothesize that exercise is key in identifying new pathways, specifically those related to cerebrovascular health, that may help a broader population of dementia patients. In summary, our research and others show that exercise benefits cerebral health by improving multiple systems including the cerebrovasculature. However, the benefits of exercise appear to decline with age, further supporting that combinatorial approaches are required to prevent cognitive decline and dementias.

Conclusions {#Sec9}
===========

This study identifies genes and pathways induced by voluntary running in young mice. These genes include those involved in cerebrovascular remodeling such as basement membrane production and angiogenesis. In addition, these data propose a mechanism that running at middle life, independent of running intensity, is less effective at activating genes relevant to cerebrovascular remodeling. These data suggest renewed efforts are needed to identify those at risk of cerebrovascular decline as early as possible, and that preventative strategies that involve exercise to enhance cerebrovascular health maybe more effective in younger compared to older individuals.

Methods {#Sec10}
=======

Mouse strains {#Sec11}
-------------

All experiments involving mice were conducted with approval and accordance described in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All experiments were approved by the Animal Care and Use Committee at The Jackson Laboratory. All mice used in this study were male C57BL/6 J (B6, stock number JR00664, The Jackson Laboratory). Mice were kept in a 12/12-h light/dark cycle and fed ad libitum 6% kcal fat standard mouse chow. A total of 48 mice were used in this study.

Exercise by voluntary running {#Sec12}
-----------------------------

Group housed mice (two-three per pen) were provided access to low profile saucer wheels (Innovive Inc) 24 h a day for 12 weeks. Sedentary mice did not have access to running wheels. In the first experiment, young mice were housed from wean (1-2mo) until the end of the experiment (4-5mo). Two cohorts of mice were used to evaluate running at the young timepoint; the first group (*n* = 6 per activity) had weights, running tracked, and blood lipid profiling, while the second group (*n* = 5 per activity) had RNA-seq run on the cortex and hippocampus. In the second experiment (*n* = 12 for running and sedentary), mice were aged without wheel access, and at 12mo were provided running wheels. For both experiments, in the final week, mice were individually housed and given a trackable low-profile running wheel (Med Associates Inc.) to estimate the running behavior for the previous 11 weeks of the experiment. Running wheel rotations were measured in 1-min bins to allow for distance traveled (sum of rotations) calculated per mouse each night. Average rotations were calculated per mouse for each tracked night. Average speed while active was calculated by isolating the minute intervals where activity was measured, and averaging the number of rotations for the minutes active. Percent of time at each speed was calculated by totaling the number of minute bins that mice ran between 0, 1--30 rotations, 31--70 rotations, 71--100 rotations and 100+ rotations and dividing by the total amount of minutes tracked.

Nuclear magnetic resonance (NMR) imaging {#Sec13}
----------------------------------------

The midlife running cohort was subjected to NMR imaging 1 week before harvest. Weight was taken and mice were briefly placed into a Plexiglas tube 2.5 in. by 8 in. which was then subjected to NMR (EchoMRI, Houston, TX). Magnetic field was measured by a 5-gauss magnet. Measurements included weight, lean muscle mass, fat mass, and water composition. Adiposity was calculated by (fat/body weight) × 100. Percentage lean muscle mass was calculated by (lean muscle mass/body weight) × 100.

Harvesting, tissue preparation and blood chemistry {#Sec14}
--------------------------------------------------

All mice were euthanized by intraperitoneal injection of a lethal dose of Ketamine (100 mg/ml)/Xylazine (20 mg/ml) and blood was collected at harvest through approved cardiac puncture protocols. Mice were perfused intracardially with 1X PBS. Brains were carefully dissected and hemisected sagittally. Hippocampus (Hippo) and cortex (Ctx), were then carefully separated and snap frozen in solid CO~2~ for RNA-sequencing. Blood was also collected in K2 EDTA (1.0 mg) microtainer tubes (BD) at harvest (non-fasted) and kept at room temperature for at least 30 min to prevent clotting and then centrifuged at 22 °C for 15 min at 5000 rpm. Plasma was carefully collected and aliquoted. Plasma was characterized on the Beckman Coulter AU680 chemistry analyzer.

RNA and protein extraction, library construction and RNA sequencing {#Sec15}
-------------------------------------------------------------------

RNA sequencing (RNA-seq) was performed by The Jackson Laboratory Genome Technologies Core. RNA extraction involved homogenization with TRIzol (Invitrogen) as previously described \[[@CR28]\]. RNA was isolated and purified using the QIAGEN miRNeasy mini extraction kit (QIAGEN) in accordance with manufacturer's instructions. RNA quality was measured via the Bioanalyzer 2100 (Agilent Technologies) and poly(A) RNA-seq sequencing libraries were compiled by TruSeq RNA Sample preparation kit v2 (Illumina). Quantification was performed using qPCR (Kapa Biosystems). RNA-seq was performed on the HiSeq 4000 platform (Illumina) for 2x100bp reads for a total of 45 million reads according to the manufacturer's instructions.

RNA-seq quality control and gene set enrichment {#Sec16}
-----------------------------------------------

Quality control for each sample was completed using NGSQCToolkit v2.3 which removed adaptors and trimmed low quality bases (Phred\< 30) \[[@CR29]\]. To quantify gene expression of the trimmed reads, we used RSEM v1.2.12 which uses Bowtie2 v2.2.0 for alignment of these reads \[[@CR30]\]. We used mouse genome mm-10 based upon the B6 reference genome. Differential gene expression (DGE) analysis was completed on the hippocampus and cortex separately, using EdgeR 3.20.9 \[[@CR31]\]. A second quality control step included filtering out genes with less than at least 1 read per million for more than one sample. Normalization of trimmed mean of M values (TMM) was performed and quasi-likelihood F-test was used to attain DGE. Differentially Expressed genes (DE genes) were identified by comparing (i) young running to young sedentary, (ii) midlife low running to midlife sedentary, and (iii) midlife high running to midlife sedentary for each tissue (cortex or hippocampus). Genes were considered DE if the False Discovery Rate was less than 0.05 (FDR \< 0.05). Given the young and midlife running were run at separate times it was not possible to directly compare the young data to the midlife data.

Ingenuity Pathway Analysis (IPA) was used to identify enriched canonical pathways for each DE gene list. Additionally, Database for Annotation, Visualization and Integrated Discovery (DAVID, v6.8) was used to identify enrichment of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and Gene Ontology (GO) terms, with the background gene sets being all trimmed normalized genes for each comparison. Enriched KEGG pathways and GO terms with FDR \< 0.05 were considered significant. Cancer-related pathways were excluded from visualization.

Statistical analyses {#Sec17}
--------------------

Details of statistical analyses of RNA-seq data are provided above. All other statistical analyses were performed in GraphPad Prism v7.0a. Body composition and lipid profiling results between the young running and young sedentary cohorts utilized an unpaired t-test. Body composition and lipid profiling results between midlife sedentary, low runners, and high runners were compared with a one-way ANOVA.

Supplementary information
=========================

 {#Sec18}

**Additional file 1: Figure S1.** Midlife runners show variation in running speed and distance. **Figure S2.** Midlife High runners show reduced adiposity due to running. **Figure S3.** CPM scatterplot of young runners compared to young sedentary in the cortex and hippocampus. **Figure S4.** CPM scatterplot of midlife runners compared to midlife sedentary in the cortex and hippocampus. **Figure S5.** Fewer DE genes in the cortex and hippocampus of midlife run mice. **Figure S6.** *Col4a1*, *Lamb2* and *Lama5* are expressed in multiple cerebrovascular-related cells. **Additional file 2: Table S2.** All genes detected by RNA-seq, used as "background" gene list for gene set enrichment analyses. **Additional file 3: Table S3.** Differentially expressed genes in the cortex comparing MidlifeRunHigh to MidlifeSed. **Additional file 4: Table S4.** Differentially expressed genes in the hippocampus comparing MidlifeRunHigh to MidlifeSed. **Additional file 5: Table S5.** Differentially expressed genes in the cortex comparing MidlifeRunLow to MidlifeSed. **Additional file 6: Table S6.** Differentially expressed genes in the hippocampus comparing MidlifeRunLow to MidlifeSed. **Additional file 7: Table S7.** Differentially expressed genes in the cortex comparing YoungRun to YoungSed. **Additional file 8: Table S8.** Differentially expressed genes in the hippocampus comparing YoungRun to YoungSed. **Additional file 9: Table S1.** Housing of Midlife Running mice. **Additional file 10: Table S9.** Expression of Laminin and Collagen IV genes in both Zheng et al., and Vanlandewijck and He et al.
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